Key facts
- This page summarizes Joshua Lehrer-Graiwer's Form 4 filing for Fulcrum Therapeutics, Inc. (FULC).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 01 May 2026, 16:15.
Joshua Lehrer-Graiwer - 23 Apr 2026 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)
- Reporting relationship
- Director
- Issuer ticker
- FULC
- Reported as of
- 23 Apr 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 01 May 2026, 16:15:07 UTC
- Prior SEC filing
- 23 Feb 2023
- Next SEC filing
- 28 Sep 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Alan Musso as attorney-in-fact for Joshua Lehrer-Graiwer
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Joshua Lehrer-Graiwer filed Form 4 for Fulcrum Therapeutics, Inc. (FULC) on 01 May 2026.
Change
- Previous filing in this sequence was filed on 23 Feb 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001789673
Primary reporting owner
Lehrer-Graiwer Joshua
- Relationship
- Director
- Address
- C/O FULCRUM THERAPEUTICS, INC., 26 LANDSDOWNE STREET, CAMBRIDGE
- Signature
- /s/ Alan Musso as attorney-in-fact for Joshua Lehrer-Graiwer
- Signature date
- 01 May 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
FULC
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- Shares
- +64,000
- Change %
- Price
- $0.000000*
- Shares after
- 64,000
- Date
- 23 Apr 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 64,000
- Exercise price
- $8.08
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
This option was granted on April 23, 2026 and is scheduled to vest in equal monthly installments until April 23, 2029, subject to continued service.